Cargando…
Emerging Biomarkers in Thyroid Practice and Research
SIMPLE SUMMARY: Tumor biomarkers are molecules at genetic or protein level, or certain evaluable characteristics. These help in perfecting patient management. Over the past decade, advanced and more sensitive techniques have led to the identification of many new biomarkers in the field of oncology....
Autores principales: | Agarwal, Shipra, Bychkov, Andrey, Jung, Chan-Kwon |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8744846/ https://www.ncbi.nlm.nih.gov/pubmed/35008368 http://dx.doi.org/10.3390/cancers14010204 |
Ejemplares similares
-
Update from the 2022 World Health Organization Classification of Thyroid Tumors: A Standardized Diagnostic Approach
por: Jung, Chan Kwon, et al.
Publicado: (2022) -
The Use of Fine-Needle Aspiration (FNA) Cytology in Patients with Thyroid Nodules in Asia: A Brief Overview of Studies from the Working Group of Asian Thyroid FNA Cytology
por: Jung, Chan Kwon, et al.
Publicado: (2017) -
Noninvasive Follicular Thyroid Neoplasm with Papillary-Like Nuclear Features in Asian Practice: Perspectives for Surgical Pathology and Cytopathology
por: Bychkov, Andrey, et al.
Publicado: (2018) -
Current Status of Thyroid Fine-Needle Aspiration Practice in Thailand
por: Keelawat, Somboon, et al.
Publicado: (2017) -
VE1 Immunohistochemistry Improves the Limit of Genotyping for Detecting BRAF(V600E) Mutation in Papillary Thyroid Cancer
por: Choden, Sonam, et al.
Publicado: (2020)